Could pregnancy exposures shape neurodevelopment? massive study aims to find out

NCT ID NCT05681923

Recruiting now Knowledge-focused Sponsor: University Hospital, Montpellier Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 1,200 families who already have a child with autism (high-risk group) and 500 families from the general population (low-risk group) starting from early pregnancy. Researchers collect biological samples and survey data to explore how genetics, environment, diet, and lifestyle may influence the development of autism and other neurodevelopmental disorders. Children are monitored until age 6, when diagnoses can be reliably made.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could identify early risk factors and pave the way for earlier detection and intervention for autism and related conditions.
What could go wrong: This is an observational study, not a treatment trial. It may take years to yield actionable insights, and findings may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autism spectrum disorder neurodevelopmental disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AUTISM SPECTRUM DISORDER NEURODEVELOPMENTAL DISORDERS

Contacts and locations

Locations

CHU Montpellier
RECRUITING

Montpellier, 34 090, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.